Literature DB >> 7693362

Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide.

C Szabó1, C C Wu, J A Mitchell, S S Gross, C Thiemermann, J R Vane.   

Abstract

This study investigates the role of endogenous platelet-activating factor (PAF) in the production of nitric oxide (NO) by constitutive and inducible isoforms of NO synthase (NOS) in endotoxin shock. In anesthetized rats, 3 hours of endotoxemia resulted in a fall in mean arterial blood pressure (MAP) from 127 +/- 5 (control) to 61 +/- 7 mm Hg and a reduction of the pressor responses to norepinephrine (NE, 1 microgram.kg-1) from 33 +/- 3 (control) to 17 +/- 2 mm Hg. Endotoxemia for 3 hours also resulted in a significant reduction in the contractile effects of NE (10(-8) to 10(-6) mol/L) in thoracic aortas ex vivo. This hyporeactivity to NE was due to an enhanced formation of NO, for it was restored by the NOS inhibitor NG-nitro-L-arginine methyl ester. Animals pretreated with the PAF receptor antagonist WEB 2086 maintained higher MAP (MAP at 180 minutes, 98 +/- 6 mm Hg) and exhibited more pronounced pressor responses to NE at 180 minutes after LPS injection. Moreover, WEB 2086 attenuated by 58% the lipopolysaccharide (LPS)-induced hyporeactivity of the rat aortic rings ex vivo. At 3 hours after LPS injection, calcium-independent NOS activity was induced in the lung. The activity of inducible NOS was significantly lower (by 31%) in lungs of rats pretreated with WEB 2086. The hypothesis that WEB 2086 attenuates the induction of NOS in vivo was substantiated in vitro by the finding that pretreatment with WEB 2086 for 30 minutes inhibited the LPS-stimulated NO production in cultured murine macrophages.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693362     DOI: 10.1161/01.res.73.6.991

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  What's in a name? eNOS and anaphylactic shock.

Authors:  Charles J Lowenstein; Thomas Michel
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

3.  Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis.

Authors:  Yong-Ping Yang; Xue-Mei Ma; Chun-Ping Wang; Jun Han; Yin-Ying Lu; Yi Xiang; Shu-Hui Su; Yong-Yi Feng
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

4.  Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia.

Authors:  C Szabó; G Haskó; B Zingarelli; Z H Németh; A L Salzman; V Kvetan; S M Pastores; E S Vizi
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

5.  Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.

Authors:  V Parikh; M Singh
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

6.  Anaphylactic shock depends on PI3K and eNOS-derived NO.

Authors:  Anje Cauwels; Ben Janssen; Emmanuel Buys; Patrick Sips; Peter Brouckaert
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

7.  Evidence for mediation of L-2-chloropropionic acid-induced delayed neuronal cell death by activation of a constitutive nitric oxide synthase.

Authors:  P S Widdowson; M Farnworth; R B Moore; D Dunn; I Wyatt
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

8.  Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.

Authors:  C C Wu; S J Chen; C Szabó; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

Authors:  M Perretti; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.